Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation].

Revista medica de Chile - 1 Sept 2008

Stehr Carlos B, Carvajal Cristian A, Lacourt Patricia, Alcaíno Hernán, Mellado Rosemarie, Cattani Andreína, Mosso Lorena M, Lavandera Sergio, Fardella Carlos E

Abstract excerpt

BACKGROUND: Type I familial hyperaldosteronism is caused by the presence of a chimaeric gene CYPl 1B1/CYP11BZ which encodes an enzyme with aldosterone synthetase activity regulated by adrenocorticotrophic hormone (ACTH). Therefore, in patients with FH I is possible to normalize the aldosterone le...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldosterone
Share to C-Reactive Protein
Share to Cytochrome P-450 CYP11B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperaldosteronism

Share to Matrix Metalloproteinase 9

Share to Paternity

Share to Steroid 11-beta-Hydroxylase

Share to Vasculitis

Source

Identifiers

PMID: 19030657
DOI: /S0034-98872008000900007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19030657-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation].PMID 19030657Read ↗

[Molecular genetics of hypertension in the human].Semantic proximity Read ↗

[Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].Semantic proximity Read ↗

Focus on increased serum angiotensin-converting enzyme level: From granulomatous diseases to genetic mutations.Semantic proximity Read ↗

Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.Semantic proximity Read ↗

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).Semantic proximity Read ↗

[Importance of the 11β-hydroxysteroid dehydrogenase enzyme in clinical disorders].Semantic proximity Read ↗

Familial Hyperaldosteronism I–IIISemantic proximity Read ↗

Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).Semantic proximity Read ↗

[Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].Semantic proximity Read ↗

Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.Semantic proximity Read ↗

Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.Semantic proximity Read ↗

Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964-1997.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.